期刊文献+

染色体核型及血清碱性磷酸酶水平在慢性粒细胞白血病病情预测中作用 被引量:1

The complex abnormal chromosome and the level of serum ALP in the prediction of the chronic myelocytic leukemia patients
原文传递
导出
摘要 目的研究慢性粒细胞白血病(CML)患者骨髓单个核细胞染色体核型与血清碱性磷酸酶(ALP)水平间变化关系,探讨细胞遗传学变化及ALP水平在患者病情及预后判断中的价值。方法选择不同时期CML患者,检测其血清ALP,并取骨髓有核细胞采用直接法或24小时培养法、R带显色技术作染色体分析。结果CML患者ALP水平高于正常对照组,加速期急变期患者复杂核型出现率及血清ALP水平显著高于慢性期患者,且ALP水平与髓内幼稚细胞数水平呈正相关,PH1阳性核型CML患者与复杂核型CML患者血清ALP水平差别不明显。结论CML患者血清ALP水平及染色体复杂核型反应该期患者疾病特征,对CML疾病分期、预后判断有价值,两者间的一致性有待进一步研究。 Objective To investigate and compare the level of serum alkaliphosphatase (ALP) and the chromosome in the patients with chronic myelocytic leukemia (CML). Methods The serum concentration of ALP were indirectly tested by chemical method, Metaphase chromosomes were prepared using direct method and culture method. Karyotyping was performed using R-banding technique. All CML patients was not including those with immunologic disease.liver,kidney disease and infective disease and were divided into the chronic phase CML and the acceleration phase or blast crisis CML. The normal group was 20 cases. Results Two group patients were higher level of ALP than the normal group. The acceleration phase or blast crisis CML patients has not only the high incidence of the complex abnormal chromosome but also the high levels of ALP than the chronic phase patients, the serum ALP level have the positive correlation with infantility cells too, but the difference of the level of serum ALP was not found between those with PH1 and those with the complex abnormal chromosome. Conclusions The high serum ALP level and high incidence of the complex abnormal chromosome in acceleration phase or blast crisis CML patients closely related their situation.
出处 《临床内科杂志》 CAS 2008年第2期111-113,共3页 Journal of Clinical Internal Medicine
基金 江苏省镇江市社会发展基金项目 编号SH2004046
  • 相关文献

参考文献10

  • 1Mitelman F,ed. ISCN( 1995):An International System for Human Cytogenetic Nomenclature. Basel (Switzerland) : Karger, 1995.
  • 2薛志科,金洁,陈志妹,楼基余,俞运彪,王云贵.25例伴复杂变异易位的慢性粒细胞白血病细胞遗传学分析[J].中华血液学杂志,2006,27(5):351-352. 被引量:6
  • 3Dotti G, Garattini E, Borleri G, et al. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine klnase activity. Br J Haematol, 1999,105 : 163-172.
  • 4邓君,饶绍琴,杜琼,杨明清.血液病患者粒细胞中碱性磷酸酶同工酶基因表达的研究[J].白血病.淋巴瘤,2001,10(4):221-223. 被引量:1
  • 5Bennett M, Stroncek DF. Recent advances in the bcr-abl negative chronic myeloproliferative diseases. J Transl Med, 2006,4:41.
  • 6Humphrey PA, Halabi S, Picus J, et al. Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 150005/9480. Clin Genitourin Cancer,2006,4:269-74.
  • 7Ross RW, Halabi S, Ou SS, et al. Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer-a Cancer and Leukemia Group B study. Clin Cancer Res,2005,11:8109-8113.
  • 8Gwang Kim J, Kyun Sohn S, Hwan Kim D,et al. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma,2005,46:885-891.
  • 9Hatta Y ,Takeuchi J, Saitoh T, et al. WT1 expression level and clinical factors in multiple myeloma. J Exp Clin Cancer Res, 2005,24:595- 599.
  • 10Paydas S,Tanriverdi K,Yavuz S, et al. PRAME mRNA levels in cases with acute leukemia:clinical importance and future prospects. Am J Hematol, 2005,79 : 257 -261.

二级参考文献12

  • 1de Braekeleer M.Breakpoint distribution in variant Philadelphia translocation in chronic myeloid leukemia.Cancer Genet Cytogenet,1986,23:167-170.
  • 2Mitelman F.Catalog of chromosome aberrations in cancer(ed 2).In:Sandburg AA,ed.Progress and Topic in Cytogenetics.Vol 5.New York:Liss,1985.
  • 3王祖贻 申雪英 潘明理.Ph阳性慢性粒细胞白血病的变异易位和其他核型变化[J].中华血液学杂志,1987,8:26-27.
  • 4Espinoza JP,Cardenas V J,Jimenez EA,et al.A complex translocation (9 ;22; 16) (q34; q11.2; p13) in chronic myelocytic leukemia.Cancer Genet Cytogenet,2005,157:175-177.
  • 5Emberger W,Behmel A,Tschernigg M,et al.Chronic myeloid leukemia with a rare variant Philadelphia translocation:t (9; 10; 22)(q34 ;q22 ;q11).Cancer Genet Cytogenet,2001,129:76-79.
  • 6Dierlamm J,Michaux L,Stefanova M,et al.Novel Philadelphia variant t (Y; 9; 22) (q12; q34; q11) in a case of chronic myeloid leukemia.Cancer Genet Cytogenet,1999,114:150-153.
  • 7Sato N,Mizukami H,Tani K,et al.Regulation of mRNA levels of alkaline phosphatase gene in neutrophilic granulocytes by graulocyte colony-stimulating factors and retinoic acid[].European Journal of Haematology.1991
  • 8Sato N,Takahashi Y,Asano S.Preferetial usage of the bonetype leader sequence for the transcripts of liver bone kidney type alkaline phosphatase gene in neutrophilic granulocytes[].Blood.1994
  • 9Weiss M J,Ray K,Henthorn P S,et al.Structure of the human liver bone kindney alkaline phosphatase gene[].Biological Chemistry.1998
  • 10Chomczynski P,Sacchi N.singel -step method of RNA isolation by acid guanidinium thiocyanate-phenol -chloroform extration[].Analytical Biochemistry.1987

共引文献5

同被引文献12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部